Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Operating Leases (2020 - 2025)

Journey Medical (DERM) has disclosed Operating Leases for 6 consecutive years, with $44000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases changed N/A year-over-year to $44000.0, compared with a TTM value of $44000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $118000.0, up 1211.11% over the prior year.
  • Operating Leases was $44000.0 for Q3 2025 at Journey Medical, down from $69000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $118000.0 in Q4 2024 and bottomed at $9000.0 in Q4 2023.
  • Average Operating Leases over 5 years is $64300.0, with a median of $64000.0 recorded in 2023.
  • The sharpest move saw Operating Leases tumbled 91.67% in 2023, then skyrocketed 1211.11% in 2024.
  • Year by year, Operating Leases stood at $24000.0 in 2021, then skyrocketed by 350.0% to $108000.0 in 2022, then crashed by 91.67% to $9000.0 in 2023, then surged by 1211.11% to $118000.0 in 2024, then plummeted by 62.71% to $44000.0 in 2025.
  • Business Quant data shows Operating Leases for DERM at $44000.0 in Q3 2025, $69000.0 in Q2 2025, and $94000.0 in Q1 2025.